AI Insight
A survey of 2,000 French women aged 40-75 conducted in June 2025 examined perceptions of artificial intelligence in organized breast cancer screening programs. The study found that while women had limited awareness of specific AI applications in medical imaging, a large majority expressed favorable attitudes toward using AI for breast cancer diagnosis. Despite ongoing barriers to screening participation, respondents viewed AI as a potential tool to increase engagement with organized screening programs.
Why it matters
Understanding public acceptance of AI in medical screening is crucial for successful implementation of these technologies in healthcare systems. The findings suggest that AI integration could help address low participation rates in breast cancer screening programs, though educational efforts may be needed to increase awareness of AI capabilities.
⚠️ Preprint – Noch nicht peer-reviewed
Dieser Artikel wurde noch nicht von unabhängigen Experten begutachtet. Die Ergebnisse sind vorläufig und sollten mit Vorsicht interpretiert werden.
This study aims to assess women’s perceptions of artificial intelligence (AI) used in breast cancer screening in France by examining their knowledge of AI and the barriers to their participation in organized screening. The results of a survey conducted in June 2025 among a national sample of 2000 women (aged 40-75) reveal limited participation and persistent concerns among women. Nevertheless, despite a low awareness of specific AI applications, a large majority of the women surveyed are very favorable to the use of AI in breast cancer diagnosis, even considering it a lever to increase screening participation.